Scaffold-Hopping Cascade Yields Potent Inhibitors of 5-Lipoxygenase

被引：32

作者：

Hofmann, Bettina ^{[1
]}

Franke, Lutz ^{[1
]}

Proschak, Ewgenij ^{[1
]}

Tanrikulu, Yusuf ^{[1
]}

Schneider, Petra ^{[2
]}

Steinhilber, Dieter ^{[3
]}

Schneider, Gisbert ^{[1
]}

机构：

[1] Univ Frankfurt, Inst Organ Chem & Chem Biol, ZAFES CMP, D-60323 Frankfurt, Germany

[2] Schneider Consulting GbR, D-61440 Oberursel, Germany

[3] Univ Frankfurt, Inst Pharmaceut Chem, ZAFES, D-60438 Frankfurt, Germany

来源：

CHEMMEDCHEM | 2008年 / 3卷 / 10期

关键词：

bioisosters; cheminformatics; drug discovery; inflammation; virtual screening;

D O I：

10.1002/cmdc.200800153

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

(Chemical Equation Presented) A two-step iterative approach to virtual screening can identifypotent lead scaffolds as demonstrated for 5-lipoxygenase inhibition, a validated target for the treatment of inflammation and allergic reactions. Four cycles of virtual screening using both 3D- and 2D-based methods, and substructure searching were performed, and cell-based assays were used to further refine the lead selection at each stage of the process. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：1535 / 1538

页数：4

共 50 条

[21] Scaffold-hopping of bioactive flavonoids: Discovery of aryl-pyridopyrimidinones as potent anticancer agents that inhibit catalytic role of topoisomerase IIα
Priyadarshani, Garima
Amrutkar, Suyog
Nayak, Anmada
Banerjee, Uttam C.
Kundu, Chanakya N.
Guchhait, Sankar K.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 122 : 43 - 54
[22] Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach
Zaytsev, Andrey
Dodd, Barry
Magnani, Matteo
Ghiron, Chiara
Golding, Bernard T.
Griffin, Roger J.
Liu, Junfeng
Lu, Xiaohong
Micco, Iolanda
Newell, David R.
Padova, Alessandro
Robertson, Graeme
Lunec, John
Hardcastle, Ian R.
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (02) : 180 - 189
[23] 5-Lipoxygenase inhibitors -: patent and literature activity during 2001-2004
Pommery, N
Massingham, R
Hénichart, JP
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (01) : 13 - 26
[24] Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis
vandeKerkhof, PCM
vanPelt, H
Lucker, GPH
Steijlen, PM
Heremans, A
SKIN PHARMACOLOGY, 1996, 9 (05): : 307 - 311
[25] 5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors
Yu, Sun-Chol
Kuhn, Hartmut
Daniliuc, Constantin-Gabriel
Ivanov, Igor
Jones, Peter G.
du Mont, Wolf-Walther
ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (04) : 828 - 834
[26] Active Compounds in Zingiber officinale as Possible Redox Inhibitors of 5-Lipoxygenase Using an In Silico Approach
Stephanie Ley-Martinez, Jaqueline
Erick Ortega-Valencia, Jose
Garcia-Barradas, Oscar
Jimenez-Fernandez, Maribel
Uribe-Lam, Esmeralda
Ivan Vencedor-Meraz, Carlos
Oliva-Ramirez, Jacqueline
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
[27] Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A4 Hydrolase
Teder, Tarvi
Koenig, Stefanie
Singh, Rajkumar
Samuelsson, Bengt
Werz, Oliver
Garscha, Ulrike
Haeggstrom, Jesper Z.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
[28] Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation
Krauth, Verena
Bruno, Ferdinando
Pace, Simona
Jordan, Paul M.
Temml, Veronika
Romano, Maria Preziosa
Khan, Haroon
Schuster, Daniela
Rossi, Antonietta
Filosa, Rosanna
Werz, Oliver
BIOCHEMICAL PHARMACOLOGY, 2023, 208
[29] PRECLINICAL PHARMACOLOGY OF ICI-D2138, A POTENT ORALLY-ACTIVE NONREDOX INHIBITOR OF 5-LIPOXYGENASE
MCMILLAN, RM
SPRUCE, KE
CRAWLEY, GC
WALKER, ERH
FOSTER, SJ
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) : 1042 - 1047
[30] Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity
Nandha, B.
Ramareddy, Sureshbabu A.
Kuntal, Hazra
ARCHIV DER PHARMAZIE, 2018, 351 (06)

← 1 2 3 4 5 →